Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca Tops Earnings Estimate, But Crestor and Onglyza Sales Slow
TheStreet.com
Thu, 04/27/17 - 09:23 am
Tags:
AstraZeneca, earnings
Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi
BioPharma Dive
Wed, 04/26/17 - 09:29 pm
Tags:
earnings, AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene, Roche, Sanofi
What Analysts Predict for AstraZeneca’s 1Q17 Earnings
Market Realist
Wed, 04/26/17 - 10:57 am
Tags:
AstraZeneca, earnings
Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?
Motley Fool
Tue, 04/25/17 - 11:10 am
Tags:
Valeant Pharmaceuticals, Siliq, drug pricing, brodalumab, psoriasis, AstraZeneca, Amgen
AstraZeneca moving costs rise as new HQ nears completion
Yahoo/Reuters
Tue, 04/25/17 - 11:06 am
Tags:
AstraZeneca, R&D
FDA explains why it rejected AstraZeneca's ZS-9
BioPharma Dive
Fri, 04/21/17 - 11:27 am
Tags:
FDA, AstraZeneca, ZS-9
AstraZeneca Seroquel whistleblower suit diminished but preserved by federal judge
Fierce Pharma
Thu, 04/20/17 - 09:52 am
Tags:
AstraZeneca, Seroquel, off-label, whistleblower lawsuits
FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Fierce Pharma
Wed, 04/19/17 - 04:12 pm
Tags:
FDA, AstraZeneca, ZS-9, ZS Pharma, hyperkalemia
A final flop signals the bitter end to Circassia’s big plans for allergy R&D
Endpoints
Tue, 04/18/17 - 09:34 am
Tags:
Circassia, R&D, allergies, AstraZeneca
When is bad press not so bad? When it's building a market, AstraZeneca says of its Super Bowl experiment
Fierce Pharma
Tue, 04/11/17 - 10:03 am
Tags:
AstraZeneca, opioid-induced constipation, opioids
FDA Approves Astra's Lung Cancer Drug
Investopedia
Fri, 03/31/17 - 10:09 pm
Tags:
AstraZeneca, FDA, Tagrisso, non-small cell lung cancer
AstraZeneca Shares Progress on LYNPARZA™ (olaparib) Tablets in the US
Yahoo
Wed, 03/29/17 - 09:05 am
Tags:
AstraZeneca, Lynparza, olaparib, ovarian cancer
AstraZeneca’s Lung Cancer Drug Secures China Approval
Investopedia
Mon, 03/27/17 - 09:38 am
Tags:
AstraZeneca, China, Tagrisso, non-small cell lung cancer
What to Expect from AstraZeneca’s Farxiga in 2017
Market Realist
Thu, 03/23/17 - 09:28 am
Tags:
AstraZeneca, Farxiga, diabetes
7 Pharma Plays With Emerging Market Potential
Barron's
Wed, 03/22/17 - 10:59 pm
Tags:
emerging markets, Pfizer, GSK, Sanofi, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Dr Reddy's
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
Market Realist
Tue, 03/21/17 - 06:56 pm
Tags:
Japan, AstraZeneca, Tagrisso
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Fierce Pharma
Mon, 03/20/17 - 10:57 am
Tags:
AstraZeneca, JNJ, Eli Lilly, Boehringer Ingelheim, diabetes, Farixga, Invokana, Jardiance, SGLT2 inhibitor
$230M deal: AstraZeneca forms COPD drugs collaboration
Bizjournals.com
Sat, 03/18/17 - 09:28 am
Tags:
AstraZeneca, COPD, Circassia, Duaklir, Tudorza
FDA Rejects AstraZeneca’s Hyperkalemia Drug
Investopedia
Fri, 03/17/17 - 09:29 am
Tags:
AstraZeneca, FDA, hyperkalemia, ZS-9
AZ gears up for FDA filing as PARP inhibitor Lynparza wins big in ovarian cancer trial
Fierce Pharma
Tue, 03/14/17 - 04:43 pm
Tags:
AstraZeneca, PARP inhibitors, Lynparza, FDA, ovarian cancer, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.